Skip to main content
TipRanks
Go Ultimate75% OFF

Milestone Pharmaceuticals (MIST) Stock Statistics & Valuation Metrics

829 Followers

Total Valuation

Milestone Pharmaceuticals has a market cap or net worth of $45.44M. The enterprise value is $120.40M.

Market Cap
$45.44M
Enterprise Value
$120.40M

Share Statistics

Milestone Pharmaceuticals has 124,498,695 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
124,498,695
Owned by Insiders
0.88%
Owned by Institutions
31.42%

Financial Efficiency

Milestone Pharmaceuticals’s return on equity (ROE) is -1.51 and return on invested capital (ROIC) is -62.00%.

Return on Equity (ROE)
-1.51
Return on Assets (ROA)
-0.56
Return on Invested Capital (ROIC)
-62.00%
Return on Capital Employed (ROCE)
-0.63
Revenue Per Employee
40.68K
Profits Per Employee
-1.66M
Employee Count
38
Asset Turnover
0.01
Inventory Turnover
0.18

Valuation Ratios

The current PE Ratio of Milestone Pharmaceuticals is -0.58. Milestone Pharmaceuticals’s PEG ratio is -0.08.

PE Ratio
-0.58
PS Ratio
10.16
PB Ratio
-9.81
Price to FCF
-0.71
Price to Operating Cash Flow
-0.80
PEG Ratio
-0.08

Income Statement

In the last 12 months, Milestone Pharmaceuticals had revenue of 1.55M and earned -63.06M in profits. Earnings per share was -0.75.

Revenue
1.55M
Gross Profit
1.43M
Operating Income
-62.48M
Pretax Income
-63.40M
Net Income
-63.06M
EBITDA
-59.45M
Earnings Per Share (EPS)
-0.75

Cash Flow

In the last 12 months, operating cash flow was -76.12M and capital expenditures -85,222, giving a free cash flow of -76.16M billion.

Operating Cash Flow
-76.12M
Free Cash Flow
-76.16M
Free Cash Flow per Share
-0.54

Dividends & Yields

Milestone Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-145.82%
Earnings Yield
-165.59%

Stock Price Statistics

Beta
2.51
52-Week Price Change
-82.20%
50-Day Moving Average
0.80
200-Day Moving Average
1.30
Relative Strength Index (RSI)
23.65
Average Volume (3m)
1.48M

Important Dates

Milestone Pharmaceuticals upcoming earnings date is Mar 25, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 13, 2026
Next Earnings Date
Mar 25, 2027
Ex-Dividend Date
―

Financial Position

Milestone Pharmaceuticals as a current ratio of 8.01, with Debt / Equity ratio of 139.76%

Current Ratio
8.01
Quick Ratio
7.96
Debt to Market Cap
0.34
Net Debt to EBITDA
0.25
Interest Coverage Ratio
-16.28

Taxes

In the past 12 months, Milestone Pharmaceuticals has paid -345.00K in taxes.

Income Tax
-345.00K
Effective Tax Rate
0.01

Enterprise Valuation

Milestone Pharmaceuticals EV to EBITDA ratio is 0.37, with an EV/FCF ratio of 0.41.

EV to Sales
-5.90
EV to EBITDA
0.37
EV to Free Cash Flow
0.41
EV to Operating Cash Flow
0.41

Balance Sheet

Milestone Pharmaceuticals has $145.35M in cash and marketable securities with $60.94M in debt, giving a net cash position of $84.42M billion.

Cash & Marketable Securities
$145.35M
Total Debt
$60.94M
Net Cash
$84.42M
Net Cash Per Share
$0.68
Tangible Book Value Per Share
-$0.04

Margins

Gross margin is 91.95%, with operating margin of -1728.44%, and net profit margin of -1844.80%.

Gross Margin
91.95%
Operating Margin
-1728.44%
Pretax Margin
-1846.85%
Net Profit Margin
-1844.80%
EBITDA Margin
-1616.34%
EBIT Margin
-1620.18%

Analyst Forecast

The average price target for Milestone Pharmaceuticals is $4.33, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target
$4.33
Price Target Upside
949.23% Upside
Analyst Consensus
Strong Buy
Analyst Count
6
Revenue Growth Forecast
―
EPS Growth Forecast
12.79%

Scores

Smart Score
2
AI Score
45